A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Paul Johnson
Advertisement
Paul Johnson is scientist at Pfizer Global Research and Development Global Biologics, Bioprocess R&D
Articles by Paul Johnson
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Advertisement
Latest Updated Articles
The Development and Application of a Monoclonal Antibody Purification PlatformPublished: October 2nd 2009 | Updated:
The Development and Application of a Monoclonal Antibody Purification PlatformPublished: March 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
2
Achieving Real Impact Navigating the Data and Regulatory Barriers to AI Adoption in Bio/pharma
3
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
4
RNAnalytics CPHI Interview, Part Two: Nanoparticle Case Studies and Response to US mRNA Pullback
5
